Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 54 Neoplasms 38 Lung Neoplasms 24 Colorectal Neoplasms 24 Prostatic Neoplasms 17 Uterine Cervical Neoplasms 14 Motor Activity 13 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Hematologic Neoplasms 9 Anxiety Disorders 9 Urinary Bladder Neoplasms 8 Obesity 8 Melanoma 8 Lymphoma 8 Depression 8 Ovarian Neoplasms 7 Endometrial Neoplasms 7 Vulvar Neoplasms 6 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Papillomavirus Infections 5 Pain 5 Leukemia, Myeloid, Acute 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4

Interventions

Pemetrexed 9 Nivolumab 8 Cisplatin 8 Carboplatin 8 pembrolizumab 7 130-nm albumin-bound paclitaxel 7 Gemcitabine 6 padeliporfin 5 durvalumab 5 Paclitaxel 5 Bevacizumab 5 palbociclib 4 napabucasin 4 atezolizumab 4 Irinotecan 4 Fulvestrant 4 Fluorouracil 4 Drug Therapy 4 Cyclophosphamide 4 ribociclib 3 osimertinib 3 cobimetinib 3 alectinib 3 abemaciclib 3 Trastuzumab 3 Sunitinib 3 Radiosurgery 3 Mitomycin 3 Docetaxel 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms by Site × Methods × Clear all

NCT03569605 2021-04-01

IMPACT

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed

Motor Activity, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡